mevastatin has been researched along with Multiple Myeloma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, ZR; Du, XY; Liu, ZL; Luo, JM; Wang, FX; Yang, JC; Yao, L; Zhang, XJ | 1 |
| Barna, G; Bocsi, J; Jánosi, J; Kopper, L; Nagy, K; Sebestyén, A; Vályi-Nagy, I | 1 |
| Bertieri, R; Boccarelli, A; Cirulli, T; Coluccia, AM; Coluccia, M; Dammacco, F; Di Pietro, G; Giannini, T; Mangialardi, G; Ribatti, D; Scavelli, C; Vacca, A | 1 |
| Croucher, PI; Helfrich, MH; Rogers, MJ; Russell, RG; Shipman, CM | 1 |
4 other study(ies) available for mevastatin and Multiple Myeloma
| Article | Year |
|---|---|
[In vitro effects of mevastatin on the proliferation and apoptosis in human multiple myeloma cell line U266].
Topics: Apoptosis; Cell Division; Cell Line, Tumor; G1 Phase; Genes, bcl-2; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Multiple Myeloma | 2004 |
[Mevastatin induced apoptosis in U266 human myeloma cell line].
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Membrane Glycoproteins; Multiple Myeloma; Proteoglycans; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Syndecan-1; Syndecans | 2004 |
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma.
Topics: Adult; Aged; Base Sequence; Blotting, Western; Culture Media, Conditioned; Diphosphonates; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Imidazoles; Lovastatin; Male; Middle Aged; Multiple Myeloma; Neovascularization, Pathologic; Phenotype; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2007 |
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Diphosphonates; Diterpenes; Enzyme Inhibitors; Farnesol; Humans; Lovastatin; Mevalonic Acid; Multiple Myeloma; Protein Prenylation; Tumor Cells, Cultured | 1998 |